Stock HAPV3 HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hapvida Participações e Investimentos S.A.

Equities

HAPV3

BRHAPVACNOR4

Managed Healthcare

Market Closed - Sao Paulo
Other stock markets
 04:07:40 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.78 BRL +3.85% Intraday chart for Hapvida Participações e Investimentos S.A. +5.00% -15.06%
Apr. 01 Transcript : Hapvida Participações e Investimentos S.A., Q4 2023 Earnings Call, Apr 01, 2024
Mar. 29 Hapvida Participações E Investimentos S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 46,944 56,690 40,394 36,150 33,353 28,332 - -
Enterprise Value (EV) 1 46,385 56,073 38,458 42,003 38,149 32,125 29,559 25,093
P/E ratio 54.8 x 72.7 x 79.8 x -46.2 x -44.5 x 84 x 28.1 x 19.9 x
Yield 0.46% 0.36% 0.08% - - 0.53% 1.03% 2.25%
Capitalization / Revenue 8.33 x 6.63 x 4.09 x 1.52 x 1.22 x 0.97 x 0.89 x 0.82 x
EV / Revenue 8.23 x 6.55 x 3.89 x 1.77 x 1.39 x 1.1 x 0.93 x 0.73 x
EV / EBITDA 43.8 x 27.8 x 25.7 x 20 x 13 x 8.78 x 6.45 x 4.8 x
EV / FCF 121 x 58.4 x -77.6 x 178 x 19.9 x 27.7 x 11.9 x 8.3 x
FCF Yield 0.83% 1.71% -1.29% 0.56% 5.03% 3.61% 8.42% 12.1%
Price to Book 6.54 x 7.24 x 3.8 x 0.74 x - 0.58 x 0.56 x 0.52 x
Nbr of stocks (in thousands) 3,673,263 3,714,927 3,891,570 7,116,195 7,495,107 7,495,107 - -
Reference price 2 12.78 15.26 10.38 5.080 4.450 3.780 3.780 3.780
Announcement Date 3/26/20 3/18/21 3/23/22 2/28/23 3/28/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,634 8,555 9,883 23,749 27,383 29,204 31,760 34,566
EBITDA 1 1,059 2,020 1,495 2,100 2,932 3,659 4,583 5,225
EBIT 1 981.7 1,267 543.3 -155.9 681.2 1,537 2,677 3,726
Operating Margin 17.42% 14.81% 5.5% -0.66% 2.49% 5.26% 8.43% 10.78%
Earnings before Tax (EBT) 1 1,152 1,133 492.9 -1,448 -673.7 615.5 1,598 2,164
Net income 1 866.5 785.3 497.8 -777.2 -739.8 322.9 1,330 2,191
Net margin 15.38% 9.18% 5.04% -3.27% -2.7% 1.11% 4.19% 6.34%
EPS 2 0.2332 0.2100 0.1300 -0.1100 -0.1000 0.0450 0.1343 0.1900
Free Cash Flow 1 383 959.6 -495.7 235.9 1,919 1,161 2,490 3,024
FCF margin 6.8% 11.22% -5.02% 0.99% 7.01% 3.98% 7.84% 8.75%
FCF Conversion (EBITDA) 36.16% 47.52% - 11.23% 65.43% 31.73% 54.33% 57.89%
FCF Conversion (Net income) 44.2% 122.2% - - - 359.51% 187.16% 138.04%
Dividend per Share 2 0.0592 0.0542 0.008290 - - 0.0200 0.0391 0.0849
Announcement Date 3/26/20 3/18/21 3/23/22 2/28/23 3/28/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,559 2,599 4,842 6,084 6,321 6,502 6,726 6,840 6,882 6,936 7,058 7,207 7,368 7,384 7,526
EBITDA 1 321.9 388.4 414 582.3 505.3 598.7 634.5 606.2 742 949.7 862 793.3 879.2 1,045 1,140
EBIT 1 83.6 155.5 191.1 -131.7 109.2 -100.6 93.3 64 102.9 420.9 312.5 256.8 364.2 480.5 -
Operating Margin 3.27% 5.98% 3.95% -2.16% 1.73% -1.55% 1.39% 0.94% 1.5% 6.07% 4.43% 3.56% 4.94% 6.51% -
Earnings before Tax (EBT) 58.9 133.7 - -391 -236.3 -616.3 -336.7 -183 -268.5 114.5 - - - - -
Net income 1 43.7 200 -182 -312.3 35.15 -316.7 -341.6 -161.1 -205.7 -30.65 -21.87 -48.32 43.45 - -
Net margin 1.71% 7.7% -3.76% -5.13% 0.56% -4.87% -5.08% -2.36% -2.99% -0.44% -0.31% -0.67% 0.59% - -
EPS 0.0100 0.0500 -0.0300 -0.0500 0.0100 -0.0400 -0.0500 -0.0200 -0.0300 -0.0100 - - - - -
Dividend per Share 2 - 0.008290 - - - - - - - - - - - - -
Announcement Date 11/11/21 3/23/22 5/16/22 8/11/22 11/9/22 2/28/23 5/16/23 8/9/23 11/9/23 3/28/24 - - - - -
1BRL in Million2BRL
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 5,853 4,796 3,794 1,227 -
Net Cash position 1 559 617 1,937 - - - - 3,239
Leverage (Debt/EBITDA) - - - 2.787 x 1.635 x 1.037 x 0.2677 x -
Free Cash Flow 1 383 960 -496 236 1,919 1,161 2,490 3,025
ROE (net income / shareholders' equity) 16% 10.4% 5.41% -2.62% -1.51% 2.9% 4.37% 5.6%
ROA (Net income/ Total Assets) - - - 2.45% -1% 1.64% 2.4% -
Assets 1 - - - -31,698 74,185 19,692 55,389 -
Book Value Per Share 2 1.950 2.110 2.740 6.860 - 6.570 6.800 7.220
Cash Flow per Share 2 0.1900 0.3600 0.0600 0.1400 0.3100 0.2800 - -
Capex 1 274 366 708 736 412 1,075 993 935
Capex / Sales 4.86% 4.28% 7.16% 3.1% 1.5% 3.68% 3.13% 2.7%
Announcement Date 3/26/20 3/18/21 3/23/22 2/28/23 3/28/24 - - -
1BRL in Million2BRL
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Hapvida Participações e Investimentos S.A.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
3.78 BRL
Average target price
5.64 BRL
Spread / Average Target
+49.21%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector HMO Medical Centers

1st Jan change Capi.
HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A. Stock Hapvida Participações e Investimentos S.A.
-15.06% 5.53B
ODONTOPREV S.A. Stock Odontoprev S.A.
+0.60% 1.26B
HMO Medical Centers
  1. Stock Market
  2. Equities
  3. HAPV3 Stock
  4. Financials Hapvida Participações e Investimentos S.A.